Archive
A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Contributors: Cowen, Philip J; Godlewska, Beata R; Holder, Adele A; Macdonald, Orla; Sharpley, Ann L; Williams, Clare
Subjects: Bipolar Disorder, Hypomania, Mania
Psychosocial markers of age at onset in bipolar disorder: a machine learning approach
Contributors: Geddes, John R; Joyce, Dan W; Saunders, Kate E.A.
Subjects: Bipolar Disorder
An Overview of Sleep and Circadian Rhythms in Bipolar Disorder
Contributors: Saunders, Kate E.A.
Subjects: Bipolar Disorder, Insomnia, Sleep
Characterizing Affective Variability in Bipolar Disorder and Borderline Personality Disorder, and the Effects of Lithium, Using a Generative Model of Affect
Contributors: Browning, Michael; Geddes, John R; Goodwin, Guy M; Harmer, Catherine J; Harrison, Paul J; Saunders, Kate E.A.
Subjects: Bipolar Disorder, Borderline Personality Disorder, Lithium